CAR-T therapy is emerging as one of the most promising cancer therapeutics, with this in mind, Creative Biolabs developed a comprehensive set of integrated services including CAR-T discovery, CAR-T engineering, CAR-T in vitro validation, CAR-T in vivo animal testing, CAR-T manufacturing. We have ample expertise and talented team to guide our clients, every step of the way, with the aim to accelerate and promote the progression of your CGT product.

Creative Biolabs supports the discovery of cellular and gene therapies via a consultative-based and strategic approach with great expertise and scientific knowledge, plus regulatory concerns. Both individual studies and integrated programs are designed covering all aspects of cellular and gene therapies, such as TCR-T cell therapy, CAR-T cell therapy, CAR-NK cell therapy, CAR-MA cell therapy and OV cell therapy. Our discovery services are provided to primarily mitigate risk factors inherent in discovery and development of the therapeutic types. Our multidisciplinary team will accommodate the specific properties of your CGT product to design an appropriate candidate for our clients. With extensive experience and a proven ability to navigate updated regulatory landscape, our scientists design and manage a series of discovery services that reduce risk and accelerate timelines.

Features:

• Strategic advice;
• Customized program and study designs;
• Risk mitigation tactics;
• Program management;
• Regulatory advice.

With access to the biologics’ most comprehensive portfolios (from early discovery to market support), Creative Biolabs is uniquely qualified to speed your journey through drug discovery and development.

We provide the following modules of cellular and gene therapy discovery services, but not limited to these. If you are interested in any other specific requirements, please feel free to contact us to tailor a specific service for you. For current in-house services, please visit the following modules.

Highlights

• Reduce risk and accelerate timelines: the best strategy for bringing the discovery services to clients with the help of our collaborative approach and in-depth scientific knowledge and regulatory expertise of each CGT types;
• Benefit from dedicated scientific leadership: with decades of successful drug development, our seasoned experts are always ready to extend the capabilities to design early discovery solutions to meet scientific and regulatory objectives;

Under the complexities of scientific and technical challenges, cellular and gene therapy programs should be highly customized and vary greatly as per the product attributes. To move the CGT programs through regulatory approval faster, Creative Biolabs is the trusted and reliable partner who provides access to a deep scientific network and integrates different components of the services to achieve your desired milestones and push the program to market on time. Any questions, please contact us to learn more.

For Research Use Only | Not For Clinical Use

Related Services

• T Cell Receptor (TCR) T Cell Therapy
• Chimeric Antigen Receptor (CAR) T Cell Therapy
• Chimeric Antigen Receptor (CAR) NK Cell Therapy
• Chimeric Antigen Receptor (CAR) Macrophage Cell Therapy
• Oncolytic Virus (OV) Therapy
• TCR Identification
• MHC-Ligandome Mapping
• TCR Generation and Optimization
• scFv Generation and Optimization